Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease

Atherosclerosis-related cardiovascular diseases remain the leading cause of morbidity and mortality, and the search for novel diagnostic and therapeutic methods is ongoing. Mitochondrial DNA (mtDNA) mutations associated with atherosclerosis represent one of the less explored aspects of the disease p...

Full description

Bibliographic Details
Main Authors: Aleksandrina Volobueva, Andrey Grechko, Shaw-Fang Yet, Igor Sobenin, Alexander Orekhov
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/9/8/377
_version_ 1819261206972596224
author Aleksandrina Volobueva
Andrey Grechko
Shaw-Fang Yet
Igor Sobenin
Alexander Orekhov
author_facet Aleksandrina Volobueva
Andrey Grechko
Shaw-Fang Yet
Igor Sobenin
Alexander Orekhov
author_sort Aleksandrina Volobueva
collection DOAJ
description Atherosclerosis-related cardiovascular diseases remain the leading cause of morbidity and mortality, and the search for novel diagnostic and therapeutic methods is ongoing. Mitochondrial DNA (mtDNA) mutations associated with atherosclerosis represent one of the less explored aspects of the disease pathogenesis that may bring some interesting opportunities for establishing novel molecular markers and, possibly, new points of therapeutic intervention. Recent studies have identified a number of mtDNA mutations, for which the heteroplasmy level was positively or negatively associated with atherosclerosis, including the disease at its early, subclinical stages. In this review, we summarize the results of these studies, providing a list of human mtDNA mutations potentially involved in atherosclerosis. The molecular mechanisms underlying such involvement remain to be elucidated, although it is likely that some of them may be responsible for the increased oxidative stress, which plays an important role in atherosclerosis.
first_indexed 2024-12-23T19:38:07Z
format Article
id doaj.art-c1b037dd4ebd41bdaa04c4ba39022ab3
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-12-23T19:38:07Z
publishDate 2019-08-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-c1b037dd4ebd41bdaa04c4ba39022ab32022-12-21T17:33:44ZengMDPI AGBiomolecules2218-273X2019-08-019837710.3390/biom9080377biom9080377Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related DiseaseAleksandrina Volobueva0Andrey Grechko1Shaw-Fang Yet2Igor Sobenin3Alexander Orekhov4Laboratory of Gene Therapy, Biocad Biotechnology Company, Saint-Petersburg, Strelnya 198515, RussiaFederal Scientific Clinical Center for Resuscitation and Rehabilitation, Moscow 109240, RussiaInstitute of Cellular and System Medicine, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 35053, TaiwanLaboratory of Medical Genetics, Russian Cardiology Research and Production Complex, Moscow, RussiaInstitute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow 121609, RussiaAtherosclerosis-related cardiovascular diseases remain the leading cause of morbidity and mortality, and the search for novel diagnostic and therapeutic methods is ongoing. Mitochondrial DNA (mtDNA) mutations associated with atherosclerosis represent one of the less explored aspects of the disease pathogenesis that may bring some interesting opportunities for establishing novel molecular markers and, possibly, new points of therapeutic intervention. Recent studies have identified a number of mtDNA mutations, for which the heteroplasmy level was positively or negatively associated with atherosclerosis, including the disease at its early, subclinical stages. In this review, we summarize the results of these studies, providing a list of human mtDNA mutations potentially involved in atherosclerosis. The molecular mechanisms underlying such involvement remain to be elucidated, although it is likely that some of them may be responsible for the increased oxidative stress, which plays an important role in atherosclerosis.https://www.mdpi.com/2218-273X/9/8/377atherosclerosismitochondriamtDNAmutationsheteroplasmymolecular markers
spellingShingle Aleksandrina Volobueva
Andrey Grechko
Shaw-Fang Yet
Igor Sobenin
Alexander Orekhov
Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease
Biomolecules
atherosclerosis
mitochondria
mtDNA
mutations
heteroplasmy
molecular markers
title Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease
title_full Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease
title_fullStr Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease
title_full_unstemmed Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease
title_short Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease
title_sort changes in mitochondrial genome associated with predisposition to atherosclerosis and related disease
topic atherosclerosis
mitochondria
mtDNA
mutations
heteroplasmy
molecular markers
url https://www.mdpi.com/2218-273X/9/8/377
work_keys_str_mv AT aleksandrinavolobueva changesinmitochondrialgenomeassociatedwithpredispositiontoatherosclerosisandrelateddisease
AT andreygrechko changesinmitochondrialgenomeassociatedwithpredispositiontoatherosclerosisandrelateddisease
AT shawfangyet changesinmitochondrialgenomeassociatedwithpredispositiontoatherosclerosisandrelateddisease
AT igorsobenin changesinmitochondrialgenomeassociatedwithpredispositiontoatherosclerosisandrelateddisease
AT alexanderorekhov changesinmitochondrialgenomeassociatedwithpredispositiontoatherosclerosisandrelateddisease